Details for New Drug Application (NDA): 062833
✉ Email this page to a colleague
NDA 062833 describes BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE, which is a drug marketed by Pharmafair and Naska and is included in two NDAs. Additional details are available on the BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE profile page.
The generic ingredient in BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.
The generic ingredient in BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 062833
| Tradename: | BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE |
| Applicant: | Naska |
| Ingredient: | bacitracin zinc; neomycin sulfate; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM | ||||
| Approval Date: | Nov 9, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
